Latest Disease-modifying antirheumatic drug Stories
A progressive, inflammatory disease affecting the joints and organs, rheumatoid arthritis (RA) claims more than two million Americans, mostly women over age 40, among its victims. While a cure has yet to be found, the treatment of RA patients has changed considerably over the last two decades. Today, the goal of therapy is not simply symptom relief, but the prevention of long-term structural damage and functional decline.
NEW YORK (Reuters Health) - For rheumatoid arthritis (RA) sufferers who do not get adequate relief from so-called TNF-inhibitors such as etanercept or infliximab, a new drug called Orencia may provide significant clinical and functional benefits, according to a study published this week.
NEW YORK (Reuters Health) - While women with rheumatoid arthritis outnumber men, the results of a recent French study indicate that sex has little effect on the severity of the disease. Nonetheless, women more frequently undergo joint surgery.
For people with long-standing rheumatoid arthritis, combined treatment with the new â€œbiologicâ€ drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.
- The act of sweetening by admixture of some saccharine substance.